WuXi Biologics (Cayman) Inc. (WXXWY) Financials
WXXWY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 9.6 billion | 1.6 billion |
| Dec. 31, 2025 | 9.1 billion | 1.5 billion |
| June 30, 2025 | 8.4 billion | 1.6 billion |
| Dec. 31, 2024 | 7.8 billion | 1.6 billion |
WXXWY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | 66.9 million |
| Dec. 31, 2025 | 398.1 million | ? |
| June 30, 2025 | 694871 | 65.4 million |
| Dec. 31, 2024 | 253.8 million | 72.0 million |
WXXWY Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 359.1 million |
| Dec. 31, 2025 | 360.4 million |
| June 30, 2025 | 326.5 million |
| Dec. 31, 2024 | 456.9 million |
WXXWY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.9 billion | 66.3 million | 240.6 million |
| Dec. 31, 2025 | 2.3 billion | 24.2 million | 294.8 million |
| June 30, 2025 | 1.8 billion | 25.8 million | 331.4 million |
| Dec. 31, 2024 | 1.5 billion | 27.5 million | 315.6 million |
WXXWY Shares Outstanding
WXXWY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 62.6 million | 187.8 million | - |
| Dec. 31, 2025 | 257.8 million | 71.5 million | 187.1 million | - |
| June 30, 2025 | 36.2 million | 47.9 million | 165.4 million | 37.7 million |
| Dec. 31, 2024 | 282.5 million | 57.9 million | 152.4 million | 34.3 million |
WXXWY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.7 billion | 922.7 million |
| Dec. 31, 2025 | 1.7 billion | 851.7 million |
| June 30, 2025 | 1.4 billion | 795.7 million |
| Dec. 31, 2024 | 1.4 billion | 794.6 million |
WXXWY
Price: $12.44
52 week price:
Earnings Per Share: 0.35 USD
P/E Ratio: 35.43
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: China
Volume: 20500
Market Capitalization: 25.5 billion